Hyperkalemia Management

The American Heart Association identifies insufficiency of the renal system, use of renin-angiotensin-aldosterone system inhibitors, diabetes, cardiac insufficiency, and history of high potassium levels as risk factors for developing high potassium levels 1

Preparation and Administration of Potassium Solutions

A 15% solution of potassium chloride (KCl) in normal saline contains approximately 20mEq of potassium in a 10ml solution, which is a highly concentrated solution 2
To minimize risks, the American Heart Association recommends using pre-prepared potassium solutions when possible, and implementing a double-check policy where a second healthcare professional verifies the calculation, confirms the correct potassium salt is being used, and verifies the final concentration before administration 3
Pharmacy-prepared solutions should be used whenever possible rather than preparing concentrated solutions at the bedside to minimize the risk of fatal errors 3
For peripheral administration, the 15% potassium solution should be diluted to ≤80mEq/L (e.g., add the 10ml solution to at least 250ml of normal saline), while for central administration, higher concentrations can be used but still require appropriate dilution 3

The maximum rate should not exceed 10 mEq/hour under normal conditions, but in urgent cases with serum potassium <2 mEq/L or severe hypokalemia with electrocardiographic changes, up to 40 mEq/hour can be administered under continuous ECG monitoring and frequent serum potassium determinations 4, 2

Patients with hyperkalemia, severe renal insufficiency without dialysis, and untreated Addison's disease should not receive potassium administration 2, 4
Continuous monitoring of vital signs, frequent checks of renal function, and serial measurements of serum potassium are necessary during potassium administration 2, 4, 5
The use of a calibrated infusion pump is mandatory to ensure a constant and precise rate of administration, and verification of venous access is necessary to avoid extravasation 2, 4
The solution should be inspected visually for particles or discoloration before administration 4

For adult and pediatric patients, the infusion may include 20-30 mEq/L and 20-40 mEq/L of potassium, respectively, once renal function is ensured, as recommended by the American Diabetes Association 5, 4
The American Diabetes Association recommends using 20-30 mEq/L of potassium (2/3 KCl and 1/3 KPO₄) once renal function is ensured for DKA management 5
Potassium concentrations should not exceed 80-100 mEq/L for peripheral administration and higher than 100 mEq/L for central administration, using normal saline (0.9%) or hypotonic saline (0.45%) as a diluent, and administering it through a calibrated infusion pump 4